COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,635 Articles (22,913 medRxiv, 8,722 bioRxiv)

Most recent first Previous |  Page 1058: Articles 10571-10580  | Next

SARS-CoV-2 entry sites are present in all structural elements of the human glossopharyngeal and vagal nerves: clinical implications
Mezey, E., Vitale-Cross, L., Szalayova, I., Scoggins, A., Palkovits, M.
10.1101/2021.12.30.474580 — Posted: 2022-01-03
Robust expansion of phylogeny for fast-growing genome sequence data
Ye, Y., Shum, M., Tsui, J., Yu, G., Smith, D., Zhu, H., Wu, J., Guan, Y., Lam, T. T.-Y.
10.1101/2021.12.30.474610 — Posted: 2022-01-03
Reduced Pathogenicity of the SARS-CoV-2 Omicron Variant in Hamsters
McMahan, K., Giffin, V., Tostanoski, L., Chung, B., Siamatu, M., Suthar, M., Halfmann, P., Kawaoka, Y., Piedra-Mora, C., Martinot, A., Kar, S., Andersen, H., Lewis, M. G., Barouch, D. H.
10.1101/2022.01.02.474743 — Posted: 2022-01-03 Discussion: Onsite
Analysis of SARS-CoV-2 Omicron Neutralization Data up to 2021-12-22
Netzl, A., Tureli, S., LeGresley, E., Mühlemann, B., Wilks, S. H., Smith, D. J.
10.1101/2021.12.31.474032 — Posted: 2022-01-03
The efficacy of Andrographis paniculata (Burm.f.) Wall. ex Nees crude extract in hospitalised mild COVID-19 patients: a retrospective cohort study
Tanwettiyanont, J., Piriyachananusorn, N., Sangsoi, L., Boonsong, B., Sunpapoa, C., Tanamatayarat, P., Kanchanasurakit, S., Na-Ek, N.
10.1101/2022.01.01.22268609 — Posted: 2022-01-03
Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant
Liu, J., Chandrashekar, A., Sellers, D., Barrett, J., Lifton, M., McMahan, K., Sciacca, M., VanWyk, H., Wu, C., Yu, J., Collier, A.-r., Barouch, D. H.
10.1101/2022.01.02.22268634 — Posted: 2022-01-03 Discussion: Onsite
Integrin/TGF-Beta1 inhibitor GLPG-0187 blocks SARS-CoV-2 Delta and Omicron pseudovirus infection of airway epithelial cells which could attenuate disease severity
Huntington, K. E., Carlsen, L., So, E.-Y., Piesche, M., Liang, O., El-Deiry, W.
10.1101/2022.01.02.22268641 — Posted: 2022-01-03
Statistical and agent-based modelling of the transmissibility of different SARS-CoV-2 variants in England and impact of different interventions
Panovska-Griffiths, J., Swallow, B., Hinch, R., Cohen, J. A., Rosenfeld, K., Stuart, R. M., Ferretti, L., Di Lauro, F., Wymant, C., Izzo, A., Waites, W., Viner, R. M., Bonell, C., The COVID-19 Genomics UK (COG-UK) consortium, , Fraser, C., Klein, D. J., Kerr, C.
10.1101/2021.12.30.21267090 — Posted: 2022-01-03
Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design
Ayoub, H. H., Tomy, M., Chemaitelly, H., Altarawneh, H. N., Coyle, P., Tang, P., Hasan, M. R., Al Kanaani, Z., Al Kuwari, E., Butt, A. A., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Nasrallah, G., Benslimane, F., Al Khatib, H. A., YASSINE, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Abdul-Rahim, H. F., Al-Thani, M. H., Al Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2022.01.02.22268622 — Posted: 2022-01-03
Estimation the state of the Covid-19 epidemic curve in Mayotte
MANOU-ABI, S. M., SLAOUI, Y., BALICCHI, J.
10.1101/2021.12.30.21268571 — Posted: 2022-01-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).